Intra-Cellular Therapies (ITCI) PT Raised to $103 at Baird
Tweet Send to a Friend
(Updated - April 17, 2024 6:54 AM EDT)
Baird analyst Joel Beatty raised the price target on Intra-Cellular Therapies ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Joel Beatty raised the price target on Intra-Cellular Therapies ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
